Rossari Biotech Reports 22.37% Y-o-Y Net Sales Growth in Dec 2025 Quarter

• Rossari Biotech's standalone net sales reached Rs 450.66 crore in December 2025, marking a 22.37% year-on-year increase from Rs 368.28 crore in December 2024.
• Quarterly net profit remained flat at Rs 30.63 crore in December 2025, showing a marginal 0.02% decrease compared to December 2024.
• EBITDA for December 2025 stood at Rs 51.52 crore, up 1.08% from Rs 50.97 crore in the same period last year.
• Earnings Per Share (EPS) for Rossari decreased slightly to Rs 5.53 in December 2025 from Rs 5.53 in December 2024.
• Rossari shares closed at Rs 534.75 on January 14, 2026, experiencing significant negative returns of -27.28% over 6 months and -34.41% over 12 months.

Why It Matters: Rossari Biotech saw strong sales growth but flat net profit and declining share performance in Dec 2025.